Skip to main content
Log in

Economic cost of substandard and fake medicines in Tanzania

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. US dollars

  2. sulfamethoxypyrazine

Reference

  • Mori AT, et al. Economic cost of substandard and falsified human medicines and cosmetics with banned ingredients in Tanzania from 2005 to 2015: a retrospective review of data from the regulatory authority. BMJ Open : 27 Jun 2018. Available from: URL: http://dx.doi.org/10.1136/bmjopen-2018-021825

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Economic cost of substandard and fake medicines in Tanzania. PharmacoEcon Outcomes News 807, 12 (2018). https://doi.org/10.1007/s40274-018-5091-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-018-5091-z

Navigation